Nachrichten zur Edwards Lifesciences Corp. Aktie

Edwards Lifesciences (EW) Earnings Transcript

Image source: The Motley Fool.DateTuesday, Feb. 10, 2026 at 5 p.m. ETCall participantsChief Executive Officer — Bernard ZovighianChief Financial Officer…

Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics

The headline numbers for Edwards Lifesciences (EW) give insight into how the company performed in the quarter ended December 2025,…

Edwards Lifesciences Q4 Earnings on Deck: Heres What to Expect

EW gears up for Q4 earnings as investors watch TAVR momentum, fast-growing TMTT sales and steady surgical heart demand.…

EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy

Edwards Lifesciences wins FDA approval for SAPIEN M3, the first transseptal TMVR, expanding minimally invasive options for high-risk mitral regurgitation…

Should You Continue to Hold EW Stock in Your Portfolio?

Edwards Lifesciences leans on growth in Surgical Structural Heart, TAVR and TMTT, though macro pressures and litigation continue to weigh…

Edward Lifesciences - Medizintechnikkonzern profitiert von steigenden Behandlungszahlen und neuen Produkten!

Geschäftstreiber: Edward Lifesciences (EW) gehört zu den führenden Anbietern im Bereich Medizintechnik. Stark aufgestellt ist man vor allem bei Herzklappen,…

Edwards Lifesciences (EW) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter…

Edwards Lifesciences beats Q3 estimates, raises full-year outlook By Investing.com

Edwards Lifesciences beats Q3 estimates, raises full-year outlook…

Edwards Lifesciences stock upgraded by Evercore ISI on reduced competition By Investing.com

Edwards Lifesciences stock upgraded by Evercore ISI on reduced competition…

Pivotal-Point Nachverfolgung Edward Lifesciences: Herz-Spezialist überrascht mit starkem Quartal!

Edward Lifesciences ist ein Medizintechnikunternehmen, das sich auf Herzklappen, Bypass-Kanülen und Monitoring-Lösungen spezialisiert hat. Am 24. Juli wurden überzeugende Zahlen…

JenaValve Responds to FTC’s Action Against Proposed Edwards Lifesciences Acquisition

IRVINE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology announced today that the U.S. Federal Trade Commission…

Edward Lifesciences - Medizintechnikkonzern überrascht dank steigender Routineeingriffe mit sehr starken Zahlen!

Geschäftstreiber: Edward Lifesciences (EW) gehört zu den führenden Anbietern im Bereich Medizintechnik. Stark aufgestellt ist man vor allem bei Herzklappen,…

Edwards Lifesciences stock reaches 52-week high at 81.86 USD By Investing.com

Edwards Lifesciences stock reaches 52-week high at 81.86 USD…

EW Stock Climbs on Q2 Earnings & Revenue Beat, Margins Down

Edwards Lifesciences posts a second-quarter 2025 earnings and revenue beat, with strong growth in TAVR and TMTT segments despite margin…

Compared to Estimates, Edwards Lifesciences (EW) Q2 Earnings: A Look at Key Metrics

The headline numbers for Edwards Lifesciences (EW) give insight into how the company performed in the quarter ended June 2025,…

Edwards Lifesciences shares leap 7% on strong Q2 results, sales growth guidance By Investing.com

Edwards Lifesciences shares leap 7% on strong Q2 results, sales growth guidance…

Edwards Lifesciences: With A Heart Beating Strong And Steady

…

Edwards Lifesciences stock rises following competitor’s exit By Investing.com

Edwards Lifesciences stock rises following competitor’s exit…

EW Q1 Earnings & Revenues Beat, Stock Climbs, 25 Sales View Raised

Edwards Lifesciences first-quarter 2025 performance benefits from its differentiated portfolio of therapies to treat patients with structural heart disease.…

Edwards Lifesciences (EW) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Edwards Lifesciences (EW) give insight into how the company performed in the quarter ended March 2025,…

Unlocking Q1 Potential of Edwards Lifesciences (EW): Exploring Wall Street Estimates for Key Metrics

Evaluate the expected performance of Edwards Lifesciences (EW) for the quarter ended March 2025, looking beyond the conventional Wall Street…

Edwards Lifesciences SWOT analysis: stock faces TAVR headwinds, TMTT potential By Investing.com

Edwards Lifesciences SWOT analysis: stock faces TAVR headwinds, TMTT potential…

EW Stock Up on Q4 Earnings and Revenue Beat, Margins Crash

Edwards Lifesciences reports strong contributions from all product groups ??? TAVR, TTMT and surgical structural heart ??? in the fourth…

Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics

Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter…

Stifel raises Edwards Lifesciences stock to buy, target to $90 By Investing.com

Stifel raises Edwards Lifesciences stock to buy, target to $90…

Edwards Lifesciences exec sells $343,735 in stock By Investing.com

Edwards Lifesciences exec sells $343,735 in stock…

Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?

Edward Lifesciences robust potential in Structural heart and long-term strategy instill optimism.…

EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm

NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - EW

SAN DIEGO, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or…

EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm

NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline

EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline…

EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm

NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

EW INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

SAN DIEGO, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP…

EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm

NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

EW LEGAL UPDATE: Invest in Edwards Lifesciences and Lose Money? You may have been Affected by Fraud and are Urged to Contact BFA Law about the Class Action (NYSE:EW)

Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024…

EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

EW INVESTOR UPDATE: Did Edwards Lifesciences Mislead Investors Causing Losses? Contact BFA Law about the Pending Securities Fraud Lawsuit (NYSE:EW)

Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024…

Edwards Lifesciences Aktie: Überraschend vielversprechend

Die Edwards Lifesciences Aktie verzeichnete am 2. November 2024 einen erneuten Anstieg und setzte damit ihren positiven Trend der letzten…

EDWARDS LIFESCIENCES has been Sued for Securities Fraud after Stock Plummets 31%; Contact the Firm before December 13 Class Action Deadline (NYSE:EW)

Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against TD, Edwards, and UPS and Encourages Investors to Contact the Firm

NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Edwards Lifesciences Q3: Divesting Critical Care And Focusing On Structural Hearts

…

EW INVESTOR ALERT: Edelson Lechtzin LLP Urges Edwards Lifesciences Corporation (NYSE: EW) Shareholders to Seek Legal Counsel About the Pending Securities Fraud Class Action

Edelson Lechtzin LLP announces the filing of a securities fraud class action on behalf of all purchasers of Edwards Lifesciences…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Elanco, Edwards, and UPS and Encourages Investors to Contact the Firm

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

EW INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, Oct. 19, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or…

EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Investors With Large Losses in Edwards Lifesciences Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Investors With Large Losses in Edwards Lifesciences Should Contact Bernstein Liebhard LLP…

EDWARDS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm

NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

EW INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead the Edwards Lifesciences Class Action Lawsuit

SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) --  Robbins Geller Rudman & Dowd LLP announces that purchasers or…

Is it the Right Time to Hold EW Stock in Your Portfolio Now?

Edward Lifesciences Critical Care divestiture bodes well for its Structural Heart portfolio. Yet, macroeconomic issues raise worry for its operations.…

Edwards Lifesciences Aktie: Leichter Rückgang trotz solider Aussichten

Die Edwards Lifesciences Aktie verzeichnete am 21. September 2024 einen leichten Rückgang von 0,57% auf 66,84 USD. Trotz dieses kleinen…